Publications

1. Shah R, Hanna NM, Loo CE, David M, Mafra A, Fink H, et al. (2025). The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis. Nat Cancer. 6(1):194–204. https://doi.org/10.1038/s43018-024-00880-4 PMID:39747650
2. Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. (2025). The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 156(7):1336–46. https://doi.org/10.1002/ijc.35278 PMID:39688499
3. Mafra A, Laversanne M, Marcos-Gragera R, Chaves HVS, Mcshane C, Bray F, et al. (2024). The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djae321 PMID:39658225
4. Daltveit DS, Morgan E, Colombet M, Steliarova-Foucher E, Bendahhou K, Marcos-Gragera R, et al. (2025). Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022. Leukemia. 39(2):412–9. https://doi.org/10.1038/s41375-024-02452-y PMID:39567675
5. Morgan E, O’Neill C, Shah R, Langselius O, Su Y, Frick C, et al. (2024). Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 26(1):171. https://doi.org/10.1186/s13058-024-01881-y PMID:39605105
6. Piñeros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, et al. (2025). Global variations in gallbladder cancer incidence: what do recorded data and national estimates tell us? Int J Cancer. 156(7):1358–68. https://doi.org/10.1002/ijc.35232 PMID:39580808
7. Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, et al. (2024). Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25(11):1413–23. https://doi.org/10.1016/S1470-2045(24)00458-3 PMID:39393386
8. Li M, Dal Maso L, Pizzato M, Vaccarella S (2024). Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013–17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 12(11):824–36. https://doi.org/10.1016/S2213-8587(24)00223-7 PMID:39389067
9. Rey Brandariz J, Rumgay H, Ayo-Yusuf O, Edwards R, Islami F, Liu S, et al. (2024). Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study. Lancet Public Health. 9(10):e745–54. https://doi.org/10.1016/S2468-2667(24)00185-3 PMID:39366730
10. Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. (2024). Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study. BMJ. 386:e077738. https://doi.org/10.1136/bmj-2023-077738 [Erratum in: BMJ. 2024 Sep 11;386:q1995] PMID:39231588
11. Joko-Fru WY, Bardot A, Bukirwa P, Amidou S, N’da G, Woldetsadik E, et al. (2024). Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study. Lancet Glob Health. 12(6):e947–59. https://doi.org/10.1016/S2214-109X(24)00130-X PMID:38762297
12. Malagón T, Franco EL, Tejada R, Vaccarella S (2024). Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat Rev Clin Oncol. 21(7):522–38. https://doi.org/10.1038/s41571-024-00904-z PMID:38760499
13. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3):229–63. https://doi.org/10.3322/caac.21834 PMID:38572751
14. Znaor A, Eser S, Bendahhou K, Shelpai W, Al Lawati N, ELBasmi A, et al. (2024). Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: a population-based cancer registry study. Int J Cancer. 155(1):54–60. https://doi.org/10.1002/ijc.34895 PMID:38456478
15. de Paula Silva N, Colombet M, Moreno F, Erdmann F, Dolya A, Piñeros M, et al.; IICC-3 contributors (2024). Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Rev Panam Salud Publica. 48:e11. https://doi.org/10.26633/RPSP.2024.11 PMID:38410357
16. Benitez Fuentes JD, Morgan E, de Luna Aguilar A, Mafra A, Shah R, Giusti F, et al. (2024). Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis. JAMA Oncol. 10(1):71–8. https://doi.org/10.1001/jamaoncol.2023.4837 PMID:37943547
17. Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. (2023). Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 24(11):1206–18. https://doi.org/10.1016/S1470-2045(23)00444-8 PMID:37837979
18. Ginsburg O, Vanderpuye V, Beddoe AM, Bhoo-Pathy N, Bray F, Caduff C, et al. (2023). Women, power, and cancer: a Lancet Commission. Lancet. 402(10417):2113–66. https://doi.org/10.1016/S0140-6736(23)01701-4 PMID:37774725
19. Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. (2023). Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 11(11):e1700–12. https://doi.org/10.1016/S2214-109X(23)00406-0 PMID:37774721
20. Wéber A, Laversanne M, Nagy P, Kenessey I, Soerjomataram I, Bray F (2023). Gains in life expectancy from decreasing cardiovascular disease and cancer mortality – an analysis of 28 European countries 1995–2019. Eur J Epidemiol. 38(11):1141–52. https://doi.org/10.1007/s10654-023-01039-8 PMID:37676425